kezar life sciences stock news

KZR a clinical-stage biotechnology sciences company located in South San Francisco is seeking a Director. Is a clinical-stage biotechnology company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in.

Kezar Life Sciences Inc Kzr Stock Price Quote News Stock Analysis

Get the latest Kezar Life Sciences stock price and detailed information including KZR news historical charts and realtime prices.

. Kezar Life Sciences Inc a clinical-stage biotechnology company engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in. Kezar is a clinical-stage biopharmaceutical company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders. Kezar Life Sciences Inc a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders today.

Kezar Life Sciences Inc KZR shares closed today at 07 below its 52 week high of 1634 giving the company a market cap of 775M. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. The analyst firm set a price target for 2100.

Kezar Life Sciences - KZR News Today 762 015 201 As of 10252022 1200 AM ET Todays Range 747 787 50-Day Range 726 1068 52-Week Range 430. The Kezar Life Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations Crowd Wisdom Hedge Fund. Get Kezar Life Sciences Inc KZRNASDAQ real-time stock quotes news price and financial information from CNBC.

SOUTH SAN FRANCISCO Calif July 11 2022--Kezar Life Sciences Inc. Kezar Life Sciences NASDAQ. The Relative Strength RS Rating for Kezar Life Sciences stock jumped into a new percentile Friday with a rise from 78 to 81.

Kezar Life Sciences Inc. On Friday August 12 2022. KZR was reported by HC Wainwright Co.

1 day agoJob Details. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for. A high-level overview of Kezar Life Sciences Inc.

The latest price target for Kezar Life Sciences NASDAQ. Shares of the clinical-stage biotech Kezar Life Sciences KZR -026 are soaring this morning following a positive mid-stage data readout for its lupus nephritis candidate. When looking for the best stocks to buy and watch.

The stock is currently up 2023 year-to. In other news major shareholder Morningside Venture Investment sold 28700 shares of Kezar Life Sciences stock in a transaction on Monday October 3rd. Find the latest Kezar Life Sciences Inc 2KZSG stock quote history news and other vital information to help you with your stock trading and investing.

In other Kezar Life Sciences news major shareholder Morningside Venture Investment sold 28700 shares of the companys stock in a transaction that occurred on.

Billionaire Israel Englander Pulls The Trigger On These 2 Strong Buy Stocks